Aurobindo Pharma gets USFDA's approval forDuloxetine
The US Food and Drug Administration(USFDA) has given its nod to Aurobindo Pharma Ltd to produce and market Duloxetine Hydrochloride delayed-release capsules 20mg (base), 30mg (base) and 60mg (base).
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment